Mortality associated with primary hyperparathyroidism

被引:29
|
作者
Clifton-Bligh, P. B. [1 ,2 ]
Nery, M. L. [1 ]
Supramaniam, R. [3 ]
Reeve, T. S. [2 ,4 ]
Delbridge, L. [2 ,4 ]
Stiel, J. N. [1 ]
McElduff, A. [1 ,2 ]
Wilmshurst, E. G. [1 ]
Robinson, B. G. [1 ,2 ]
Fulcher, G. R. [1 ,2 ]
Learoyd, D. [1 ,2 ]
Posen, S. [1 ,2 ]
机构
[1] Royal N Shore Hosp, Dept Endocrinol, St Leonards, NSW 2065, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] NSW Canc Council, Sydney, NSW, Australia
[4] Royal N Shore Hosp, Dept Endocrine Surg, St Leonards, NSW 2065, Australia
关键词
Hyperparathyroidism; Mortality; SERUM PARATHYROID-HORMONE; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; FOLLOW-UP; VITAMIN-D; CARDIOVASCULAR MORTALITY; ESSENTIAL-HYPERTENSION; INSULIN SENSITIVITY; 25-HYDROXYVITAMIN D; RENAL-FUNCTION;
D O I
10.1016/j.bone.2014.12.067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
561 patients with primary hyperparathyroidism were followed between 1961 and 1994. Relative survival was compared to that of the Australian population studied during the same time interval. Mortality was significantly greater in the hyperparathyroid population (P < 0.001). Mortality was not greater in the patients with serum calcium levels >3.00 mmol/L compared to those with a serum calcium levels <3.00 mmol/L. 113 patients did not have parathyroid surgery. Their relative survival was not significantly different from those who had surgery but their mean serum calcium and parathyroid hormone (PTH) levels were significantly lower than those who had surgery. A re-analysis of the 453 patients followed between 1972 and 2011 was carried out and a 20-year survival analysis made of those diagnosed between 1972 and 1981 and those diagnosed between 1982 and 1991. The latter group had significantly worse relative mortality than the former group (P <0.001) but was significantly older at the time of diagnosis (56.94 +/- 14.83 vs 52.01 +/- 13.58, P <0.001). The serum calcium and serum PTH levels were not significantly different between these two groups. Crown Copyright (C) 2015 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 50 条
  • [1] Primary hyperparathyroidism
    Hermann, M.
    CHIRURG, 2010, 81 (05): : 447 - 453
  • [2] Primary hyperparathyroidism and hypertension
    Fisher, Sarah B.
    Perrier, Nancy D.
    GLAND SURGERY, 2020, 9 (01) : 143 - 150
  • [3] Thyroid pathology associated with primary hyperparathyroidism
    Sidhu, S
    Campbell, P
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 2000, 70 (04): : 285 - 287
  • [4] Primary hyperparathyroidism
    Silva, Barbara C.
    Cusano, Natalie E.
    Bilezikian, John P.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 38 (01)
  • [5] Brown tumor of the maxilla associated with primary hyperparathyroidism
    Guney, E
    Yigitbasi, OG
    Bayram, F
    Ozer, V
    Canoz, Ö
    AURIS NASUS LARYNX, 2001, 28 (04) : 369 - 372
  • [6] Two cases of primary hyperparathyroidism associated with primary cutaneous lymphoma
    Owen, CM
    Blewitt, RW
    Harrison, PV
    Yates, VM
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (01) : 120 - 123
  • [7] Cerebellar hemangiobla stoma associated with primary hyperparathyroidism
    Ogiwara, H
    Ichi, S
    Ueki, K
    Suzuki, I
    NEUROLOGIA MEDICO-CHIRURGICA, 2003, 43 (02) : 92 - 94
  • [8] ACUTE-PANCREATITIS ASSOCIATED TO PRIMARY HYPERPARATHYROIDISM
    DETOLEDO, JMO
    ELENO, MM
    MATO, JA
    ALVAREZ, C
    LORENZO, FG
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1991, 80 (03) : 210 - 212
  • [9] Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations
    Barale, Marco
    Maiorino, Federica
    Pusterla, Alessia
    Fraire, Federica
    Sauro, Lorenzo
    Presti, Michela
    Sagone, Noemi
    Ghigo, Ezio
    Arvat, Emanuela
    Procopio, Massimo
    ENDOCRINE, 2024, 86 (03) : 1140 - 1147
  • [10] Normocalcemic primary hyperparathyroidism
    Cusano, Natalie E.
    Cetani, Filomena
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (05): : 666 - 677